EGFR and non-small cell lung carcinoma: The MTOR p.L1433S mutation, found in OPT4B, is known to cause resistance after third-generation EGFR inhibitor treatment in non-small cell lung cancer (NSCLC)34, and functional analysis of MTOR p.L1433S is found to induce mTORC1 pathway activity35.